NHS, MSD collaborate to help eliminate hep C

The NHS has announced plans to collaborate with American Pharma giant MSD in a deal that could help England become the first country in the world to eliminate hepatitis C. MSD has already announced a commitment to help see hepatitis C eliminated in the UK by 2025, and over 30,000 people have already benefitted from new drugs being made available on the NHS over the last few years. The three-year ‘ambitious’ partnership will allow MSD to “work with NHS providers, local authority services, community organisations and other companies to align the diverse elements of the whole pathway for those at risk of hepatitis C infection,” according to Louise Houson, managing director, MSD UK.